Latest / Driving the Business of Science

Unlocking Value: Why Latin America is the Strategic Choice for Phase 1 Trials
Send us Fan Mail
In this episode of the Driving the Business of Science podcast, Keith Parent, CEO of Court Square Group, interviews Sara Tylosky, CEO of Farmacon Global, about the Latin American market for clinical trials. Farmacon Global, a strategic partner with a network of physicians, focuses on rare diseases, oncology, and immunology in Latin America. Sara highlights the region's diversity, cost savings, and fast recruitment, noting that Latin America represents 0.7% of global phase 1 studies but has a population of more than 660 million and 30+ qualified sites. She addresses…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.